Shortness of Breath Not Going Away? Ask Your Doctor for a Blood Test
Pulmonary alveolar proteinosis (PAP) is an ultra-rare lung disease with approximately 3,600 diagnosed cases in the United States. Unfortunately, some people are potentially living with the disease ...
MyChesCo on MSN10 天
Savara Inc. Launches Early Access Program for Rare Lung Disease Treatment
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has unveiled the Savara Early Access Program, a significant initiative aimed at ...
Savara’s Strategic Market Expansion and Diagnostic Initiatives Anchor Buy Rating
H.C. Wainwright analyst Andrew Fein maintained a Buy rating on Savara (SVRA – Research Report) today and set a price target of $10.00.
MyChesCo on MSN11 天
Savara Inc. Appoints Braden Parker as Chief Commercial Officer
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced the appointment of Braden Parker as Chief Commercial Officer, ...
Buy Rating Affirmed for Savara on Strong Prospects for Molgramostim in aPAP Treatment
Analyst Jonathan Wolleben of JMP Securities reiterated a Buy rating on Savara (SVRA – Research Report), retaining the price target of ...